Clinical Trials Browser

Phase 2 × Weight Loss × 1 year × Clear all

NCT00488072 2026-01-26

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Phase 2 Active not recruiting

Anorexia, Sleep Initiation and Maintenance Disorders, Weight Loss

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT06518837 2026-01-21

FITWISE

Phase 2 Recruiting

Weight Loss

NCT06937177 2025-12-12

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Phase 2 Recruiting

Gastrointestinal

Cachexia, Colorectal Neoplasms, Weight Loss

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Phase 2 Terminated

4 enrolled 12 charts

Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

Phase 2 Active not recruiting

129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

NCT05546476 2025-05-31

PROACC-1

Phase 2 Completed

187 enrolled 24 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss